Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

China could lace meds, security risk, PR key

Garcia and Beverly 21 (Lynne Chandler Garcia is an Assistant Professor of Political Science at the United States Air Force Academy. Michael Beverley is the Vice-Chair and Co-Founder of OneMedical Grouph; “Reinvigorating Puerto Rico’s Pharmaceutical Industry: A U.S. Security Imperative”; Centro Journal; Vol. 33 Issue 2; Summer 2021; https://web.s.ebscohost.com/ehost/detail/detail?vid=0&sid=19ad5725-03b5-438b-b2fa-185df1e64773%40redis&bdata=JnNpdGU9ZWhvc3QtbGl2ZSZzY29wZT1zaXRl#AN=152480710&db=a9h)

In the wake of COVID-19, U.S. policymakers have come to the realization that overreliance on foreign manufacture of medical devices, pharmaceuticals, and active pharmaceutical ingredients is a danger to U.S. security. Countries such as China, upon which the U.S. is dependent for pharmaceuticals, could use this dependency to its advantage in a time of conflict by withholding supplies or producing medicines that are laced with contaminants. The U.S. must take action to reshore its pharmaceutical industry and bolster American made products. Historically, Puerto Rico has led the U.S.’s pharmaceutical production, and with the current crisis, Puerto Rico has an opportunity to bolster manufacturing on the Island. This paper explores whether Puerto Rico can reinvigorate its pharmaceutical industry, thereby not only bolstering the island’s crippled economy but also helping the U.S. meet a national security imperative. [Key Words: COVID, pharmaceuticals, national security, reshore, Hurricane Maria, Puerto Rico] The COVID-19 pandemic served as a wakeup call to U.S. policymakers who have come to the grim realization that overreliance on foreign manufacture of medical devices, pharmaceuticals, and active pharmaceutical ingredients (API) is a danger to U.S. security.1 Whereas it was once the world’s leader in producing drugs and medical equipment, the U.S. is now dependent on foreign nations, especially China and India, for many pharmaceutical products, most notably APIs (the core ingredients used to manufacture finished pharmaceuticals) and generic drugs. With overreliance on foreign production of drugs and medical products both a national health problem and a national security issue, the U.S. must take action to reshore the manufacturing of pharmaceutical products. Puerto Rico leads the U.S. in pharmaceutical manufacture, although production in the territory is down after the economic downturn on the Island that began with the repeal of favorable tax laws and continued through Hurricane Maria. This paper explores whether Puerto Rico can reinvigorate its pharmaceutical industry, thereby not only bolstering the Island’s crippled economy but also helping the U.S. meet national health and security imperatives.

Sign in to recut, update, or save this card.